Infant Odontogenic Myxoma: A specific entity
Natacha Kadlub(Délégation Paris 5), Arnaud Picard(Hôpital Necker-Enfants Malades), Aurore Coulomb L’Herminé(Sorbonne Université), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Hubert Ducou Lepointe(Sorbonne Université), Valère Belle Mbou(Sorbonne Université), Julien Davrou(Sorbonne Université), Marie‐Paule Vazquez(Université Paris Cité), Edward Ansari(Hôpital Necker-Enfants Malades)
Cited by 23
Related Papers
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith–Wiedemann syndrome
|European Journal of Human Genetics|2001|173
NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
|Journal of Investigative Dermatology|2013|166
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110